Sao Paulo Medical Journal 2010-10-01

Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews.

Tamara Melnik, BernardoGarcia Soares, MariaEduardaDosSantos Puga, AlvaroNagib Atallah

Index: Sao. Paulo Med. J. 128(3) , 141-66, (2010)

Full Text: HTML

Abstract

According to some cohort studies, the prevalence of refractory schizophrenia (RS) is 20-40%. Our aim was to evaluate the effectiveness and safety of aripiprazole, paliperidone, quetiapine and risperidone for treating RS.

Related Compounds

Related Articles:

Nest building is impaired in the Ts65Dn mouse model of Down syndrome and rescued by blocking 5HT2a receptors.

2014-12-01

[Neurobiol. Learn. Mem. 116 , 162-71, (2014)]

Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator.

2014-09-01

[J. Pharmacol. Exp. Ther. 350(3) , 589-604, (2014)]

Utility of cerebrospinal fluid drug concentration as a surrogate for unbound brain concentration in nonhuman primates.

2014-01-01

[Drug Metab. Pharmacokinet. 29(5) , 419-26, (2014)]

A validated high-throughput UHPLC-MS/MS assay for accurate determination of rivaroxaban in plasma sample.

2015-01-01

[J. Thromb. Thrombolysis 39(1) , 79-88, (2015)]

Simple and sensitive screening and quantitative determination of 88 psychoactive drugs and their metabolites in blood through LC–MS/MS: Application on postmortem samples

2014-11-01

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 970 , 1-7, (2014)]

More Articles...